Elicitation of Broadly Neutralizing Antibodies against B.1.1.7, B.1.351, and B.1.617.1 SARS-CoV-2 Variants by Three Prototype Strain-Derived Recombinant Protein Vaccines

The ongoing coronavirus disease 2019 (COVID-19) pandemic is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Most of the currently approved SARS-CoV-2 vaccines use the prototype strain-derived spike (S) protein or its receptor-binding domain (RBD) as the vaccine antigen. The e...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yong, Zang, Jinkai, Xu, Shiqi, Zhang, Xueyang, Yuan, Sule, Wang, Haikun, Lavillette, Dimitri, Zhang, Chao, Huang, Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402859/
https://www.ncbi.nlm.nih.gov/pubmed/34452287
http://dx.doi.org/10.3390/v13081421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402859/
https://www.ncbi.nlm.nih.gov/pubmed/34452287
http://dx.doi.org/10.3390/v13081421

Ejemplares similares